Scancell makes two medical appointments
Scancell Holdings Plc, which is developing vaccines against cancer as well as Covid-19, has appointed Gillies O’Bryan-Tear as chief medical officer and Robert Miller as medical director.
United Kingdom
Scancell Holdings Plc, which is developing vaccines against cancer as well as Covid-19, has appointed Gillies O’Bryan-Tear as chief medical officer and Robert Miller as medical director.
United Kingdom
Suba Krishnan, an oncology expert, is to join Mereo BioPharma Group Plc on 7 December as head of clinical development where she will help advance etigilimab, a prospective treatment for advanced solid tumours.
United Kingdom
Torsten Hoffmann, inventor of the anti-emetic medicine Akynzeo, has been named chief scientific officer at Oryzon Genomics SA which is developing epigenetic-based therapeutics.
Barcelona
Spain
Silence Therapeutics Plc has promoted Marie Wikström Lindholm to it
United Kingdom
Mogrify Ltd is expanding its scientific advisory board with the appointment of three academic experts in the field of cell therapy.
United Kingdom
Stephen Squinto, an executive partner at OrbiMed Advisors LLC, has joined Genenta Science Srl as chairman of the company’s board of directors. Based in Milan, Italy, Genenta is developing a gene therapy for cancer.
MI
Italy
France-based Polyplus-transfection SA has appointed Mario Philips as chief executive officer to lead its service business for the gene and cell therapy industry.
France
Belgium-based ExeVir Bio BV has appointed Michel Kazatchkine and Stef Heylen to its board of directors. The company is developing nanobody therapies providing broad protection against viral infections, including a lead candidate targeting for coronaviruses.
Belgium
Denmark-based UNION therapeutics A/S has appointed Kim Kjoeller as chief executive, effective 1 January 2021, and Günter Ditzinger as chief technology officer.
Denmark
Stewart Kay has joined UK-based Adaptate Biotherapeutics Ltd in the new role of chief business officer (CBO).
United Kingdom
© 2021 Evernow Publishing Ltd. Powered by Drupal.